Cypress Asset Management Inc. TX Buys Shares of 10,158 UnitedHealth Group Incorporated (NYSE:UNH)

Cypress Asset Management Inc. TX acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 10,158 shares of the healthcare conglomerate's stock, valued at approximately $5,240,000. UnitedHealth Group comprises about 1.3% of Cypress Asset Management Inc. TX's investment portfolio, making the stock its 23rd largest holding.

Several other institutional investors have also recently modified their holdings of the stock. Ameriflex Group Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $411,000. United Advisor Group LLC boosted its position in UnitedHealth Group by 7.1% during the 4th quarter. United Advisor Group LLC now owns 2,106 shares of the healthcare conglomerate's stock worth $1,065,000 after purchasing an additional 140 shares during the period. Sunbeam Capital Management LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth $565,000. Challenger Wealth Management purchased a new stake in UnitedHealth Group during the 4th quarter worth $883,000. Finally, Ascent Group LLC boosted its position in UnitedHealth Group by 0.3% in the 4th quarter. Ascent Group LLC now owns 21,805 shares of the healthcare conglomerate's stock valued at $11,030,000 after buying an additional 59 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO John F. Rex purchased 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UNH traded up $2.49 during mid-day trading on Wednesday, hitting $297.49. 15,930,911 shares of the company's stock were exchanged, compared to its average volume of 6,692,516. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The stock's 50-day simple moving average is $443.90 and its 200-day simple moving average is $500.04. The firm has a market cap of $269.87 billion, a price-to-earnings ratio of 19.19, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the business posted $6.91 earnings per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Truist Financial restated a "buy" rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Raymond James lowered shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. TD Cowen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research note on Monday, May 19th. Finally, KeyCorp dropped their price target on shares of UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $441.87.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.